Otorhinolaryngological manifestations and hearing status in pediatric HIV/AIDS patients: a cross-sectional study from Northern India

Authors

  • Arunabha Chakravarti Department of ENT, LHMC, New Delhi, India
  • Arti Rai Department of ENT, RML Hospital, New Delhi, India
  • Vibhor Malhotra Department of ENT, LHMC, New Delhi, India https://orcid.org/0000-0002-3935-4629
  • Anju Seth Department of Paediatrics, LHMC, New Delhi, India

DOI:

https://doi.org/10.18203/issn.2454-5929.ijohns20251503

Keywords:

Pediatric, HIV/AIDS, Otorhinolaryngological manifestations

Abstract

Background: Pediatric HIV/AIDS patients are prone to various otorhinolaryngological (ENT) manifestations due to immunosuppression. Despite the widespread use of antiretroviral therapy (ART), ENT complications remain prevalent, affecting the quality of life. This study evaluates the ENT manifestations and hearing status in pediatric HIV/AIDS patients, emphasizing the role of regular monitoring and multidisciplinary care.

Methods: This cross-sectional observational study was conducted at tertiary medical college and hospital, in Northern India from November 2018 to March 2020. 276 HIV-positive children under 18 years were assessed for ENT manifestations and audiological abnormalities. The study analyzed the correlation between these conditions and CD4 counts.

Results: The majority of participants (39.9%) were aged 11-15 years, with a male predominance (63.8%). ENT manifestations were common, with chronic otitis media (19.6%) and oral candidiasis (19.2%) being the most frequent. Audiological assessments revealed hearing abnormalities in 25% of children, including 16.7% of children under 5 years with sensorineural hearing loss (SNHL). Nasopharyngeal lymphoid hypertrophy (8.6%) was the most common rhinological issue, while cervical lymphadenopathy was found in 80.8% of cases. Low CD4 counts were significantly associated with oral candidiasis and gingivitis but not with otitis media or rhinological conditions.

Conclusions: ENT complications remain prevalent in pediatric HIV patients despite ART. Regular ENT evaluations and early interventions are crucial for better management. Otorhinolaryngologists play a key role in multidisciplinary care to improve patient outcomes.

Metrics

Metrics Loading ...

References

Sepkowitz KA. AIDS—the first 20 years. New England J Med. 2001;344(23):1764-72. DOI: https://doi.org/10.1056/NEJM200106073442306

Alimonti JB, Ball TB, Fowke KR. Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS. J General Virol. 2003;84(7):1649-61. DOI: https://doi.org/10.1099/vir.0.19110-0

Rom WN, Markowitz SB, editors. Environmental and occupational medicine. Lippincott Williams & Wilkins. 2007; 4th edition:745.

Coutsoudis A, Kwaan L, Thomson M. Prevention of vertical transmission of HIV-1 in resource-limited settings. Expert Rev Anti-Infective Therap. 2010;8(10):1163-75. DOI: https://doi.org/10.1586/eri.10.94

World Health Organization, 2019. HIV/AIDS. Available at: https://www.who.int/news-room/fact-sheets/detail/hiv-aids. Accessed on 26 June 2020.

National AIDS Control Organisation. HIV facts and Figures. Available at: http://naco.gov.in/hiv-facts-figures. Accessed on 26 June 2020.

Prasad HK, Bhojwani KM, Shenoy V, Prasad SC. HIV manifestations in otolaryngology. Am J Otolaryngol. 2006 May 1;27(3):179-85. DOI: https://doi.org/10.1016/j.amjoto.2005.09.011

Hadfield PJ, Birchall MA, Novelli V, Bailey CM. The ENT manifestations of HIV infection in children. Clin Otolaryngol Allied Sci. 1996;21(1):30-6. DOI: https://doi.org/10.1111/j.1365-2273.1996.tb01021.x

Williams MA. Head and neck findings in pediatric acquired immune deficiency syndrome. The Laryngoscope. 1987;97(6):713-6. DOI: https://doi.org/10.1288/00005537-198706000-00013

Vlastarakos PV, Papacharalampous G, Kampessis G, Nikolopoulos TP. Diagnosis and treatment of HIV-associated manifestations in otolaryngology. Infect Dis Reports. 2012;4(1):22-9. DOI: https://doi.org/10.4081/idr.2012.e9

Singh A, Georgalas C, Patel N, Papesch M. ENT presentations in children with HIV infection. Clin Otolaryngol Allied Sci. 2003;28(3):240-3. DOI: https://doi.org/10.1046/j.1365-2273.2003.00698.x

Campanini A, Marani M, Mastroianni A, Cancellieri C, Vicini C. Human immunodeficiency virus infection: personal experience in changes in head and neck manifestations due to recent antiretroviral therapies. Acta Otorhinolaryngologicaitalica. 2005;25(1):30.

Adebola AR, Adeleke SI, Mukhtar M, Osunde OD, Akhiwu BI, Ladeinde A. Oral Manifestation of HIV/AIDS infections in paediatric Nigerian patients. Nigerian Med J: J Nigeria Med Association. 2012;53(3):150 DOI: https://doi.org/10.4103/0300-1652.104385

Ranganathan K, Geethalakshmi E, Krishna MR, Vidya KM, Kumarasamy N, Solomon S. Orofacial and systemic manifestations in 212 paediatric HIV patients from Chennai, South India. Int J Paediatr Dent. 2010;20(4):276. DOI: https://doi.org/10.1111/j.1365-263X.2010.01050.x

Kirti YK, Yashveer JK, Poorey VK. Changing Trends of HIV/AIDS in Otorhinolaryngology with CD 4+ Count Correlation. Indian J Otolaryngol Head Neck Surg. 2015;67(1):12-5. DOI: https://doi.org/10.1007/s12070-014-0712-8

Smith AF, Ianacone DC, Ensink RJ, Melaku A, Casselbrant ML, Isaacson G. Prevalence of hearing-loss among HAART-treated children in the Horn of Africa. Int J Pediatr Otorhinolaryngol. 2017;98:166-70. DOI: https://doi.org/10.1016/j.ijporl.2017.04.050

Saleem SM. Modified Kuppuswamy scale updated for year 2018. Indian J Res. 2018;7(3):436.

Gondim LA, Zonta RF, Fortkamp E, Schmeling RO. Otorhinolaryngological manifestations in children with human immunodeficiency virus infection. Int J Pediatric Otorhinolaryngol. 2000;54(2-3):97-102 DOI: https://doi.org/10.1016/S0165-5876(00)00348-7

Kumar RK, Mohan G, Reddy NV, Rao VA, Shameer M, Christopher A. Associated oral lesions in human immunodefeciency virus infected children of age 1 to 14 years in anti retroviral therapy centers in Tamil Nadu. Contemporary Clin Dentist. 2013;4(4):467. DOI: https://doi.org/10.4103/0976-237X.123043

Ianacone DC, Smith AF, Casselbrant ML, Ensink RJ, Buchinsky F, Melaku A, Isaacson G. Prevalence of chronic ear disease among HIV+ children in Sub-Saharan Africa. Int J Pediatr Otorhinolaryngol. 2017;103:133-6. DOI: https://doi.org/10.1016/j.ijporl.2017.10.024

Taipale A, Pelkonen T, Taipale M, Roine I, Bernardino L, Peltola H, Pitkäranta A. Otorhinolaryngological findings and hearing in HIV-positive and HIV-negative children in a developing country. Euro Arch Oto-Rhino-Laryngol. 2011Oct 1;268(10):1527. DOI: https://doi.org/10.1007/s00405-011-1579-x

Rzewnicki I, Olszewska E, Rogowska-Szadkowska D. HIV infections in otolaryngology. Med Sci Monit. 2012;18(3):RA17-21. DOI: https://doi.org/10.12659/MSM.882505

Sturt AS, Anglemyer AT, DuBray K, Maldonado YA. Temporal trends in otolaryngologic findings among HIV-1-infected children in a population-based cohort. Pediatric Infect Dis J. 2014;33(3):e76-80. DOI: https://doi.org/10.1097/INF.0000000000000034

Chaloryoo S, Chotpitayasunondh T, Chiengmai PN. AIDS in ENT in children. Int J Pediatr Otorhinolaryngol. 1998;44(2):103-7. DOI: https://doi.org/10.1016/S0165-5876(98)00032-9

Chandrasekhar SS, Connelly PE, Brahmbhatt SS, Shah CS, Kloser PC, Baredes S. Otologic and audiologic evaluation of human immunodeficiency virus-infected patients. Am J Otolaryngol. 2000;21(1):1-9. DOI: https://doi.org/10.1016/S0196-0709(00)80117-9

Christopher N, Edward T, Sabrina BK, Agnes N. The prevalence of hearing impairment in the 6 months–5 years HIV/AIDS-positive patients attending paediatric infectious disease clinic at Mulago Hospital. Int J Pediatr Otorhinolaryngol. 2013;77(2):262-5. DOI: https://doi.org/10.1016/j.ijporl.2012.11.013

Lauritano D, Moreo G, Oberti L, Lucchese A, Di Stasio D, Conese M, Carinci F. Oral Manifestations in HIV-Positive Children: A Systematic Review. Pathogens. 2020;9(2):88. DOI: https://doi.org/10.3390/pathogens9020088

Ponnam SR, Srivastava G, Theruru K. Oral manifestations of human immunodeficiency virus in children: An institutional study at highly active antiretroviral therapy centre in India. J Oral Maxillofacial Pathol: JOMFP. 2012;16(2):195. DOI: https://doi.org/10.4103/0973-029X.98499

Oliscovicz NF, Pomarico L, de Araújo Castro GF, Souza IP. Effect of highly active antiretroviral therapy use on oral manifestations in pediatric patients infected with HIV. Indian J Dental Res. 2015;26(2):200. DOI: https://doi.org/10.4103/0970-9290.159169

Ellison E, LaPuerta P, Martin SE. Supraclavicular masses: results of a series of 309 cases biopsied by fine needle aspiration. Head Neck: J Sci Specialties Head Neck. 1999;21(3):239-46. DOI: https://doi.org/10.1002/(SICI)1097-0347(199905)21:3<239::AID-HED9>3.0.CO;2-B

Gurney TA, Murr AH. Otolaryngologic manifestations of human immunodeficiency virus infection. Otolaryngologic Clin North Am. 2003;36(4):607-24. DOI: https://doi.org/10.1016/S0030-6665(03)00031-8

Dosemane D, Kumar V, Madi D, Kanthila J. Human Immunodeficiency Virus Infection: Does Highly Active Antiretroviral Therapy Influence Ear Nose Throat Manifestations?. Indian J Otolaryngol Head Neck Surg. 2018;70(4):555-8 DOI: https://doi.org/10.1007/s12070-018-1420-6

Jafari S, Razmpa E, Saeedinejad Z, Sadrhosseini M, Paydary K. Otolaryngological Manifestations in HIV Infected Patients, Tehran. Iran. J AIDS Clinic Res. 2012;3:1-4. DOI: https://doi.org/10.4172/2155-6113.1000160

Downloads

Published

2025-05-27

How to Cite

Chakravarti, A., Rai, A., Malhotra, V., & Seth, A. (2025). Otorhinolaryngological manifestations and hearing status in pediatric HIV/AIDS patients: a cross-sectional study from Northern India. International Journal of Otorhinolaryngology and Head and Neck Surgery, 11(3), 237–244. https://doi.org/10.18203/issn.2454-5929.ijohns20251503

Issue

Section

Original Research Articles